Podcasts about Myosin

In Episode 49 of Chain Reactions, we sit down with Mashal Waqar, Head of Marketing at Octant, and get a surprise drop-in from Griff Green, Founder of Giveth, to dig into how public goods funding actually works on Ethereum and why it matters more now than ever.We cover:– How Octant's model works: lock GLM, earn ETH, and choose to fund public goods or keep the yield– The surprisingly heated debate over what counts as a "public good" (yes, Pizza DAO came up)– Why blockchain unlocks speed, transparency, and community-driven capital allocation that traditional grants can't match– Griff's wild story of The DAO hack, how edge case funds turned into $200M+, and the launch of the new DAO Security Fund– The case for an Ethereum security coalition and why L2s need to fund shared infrastructureMashal shares her journey from running a media company with tens of millions of readers to burning out, discovering crypto through NFTs and Gitcoin, and co-authoring the first State of Web3 Grants report.We also get into real-world impact stories, from funding water filters in Gaza to helping doctors in Syria get paid through crypto, and why sustainable funding through DeFi yield beats depleting treasuries. Plus, a great riff on AI in public goods, the Zakat use case for crypto, and why execution beats everything.Timestamps00:00 – Intro and what's on everyone's timeline right now02:08 – Welcome to Chain Reactions and introducing Mashal from Octant03:54 – Mashal's journey from media founder to crypto marketer06:28 – How NFTs and Crypto Covens pulled her back into Web308:53 – Co-authoring the first State of Web3 Grants report and discovering Octant10:25 – What Octant is and how the GLM staking model works13:15 – What actually counts as a public good (and the Pizza DAO debate)16:49 – The $1M Ethereum creator round and lessons from vetting 1,000+ applications18:30 – DeFi vaults, sustainable funding, and the new StreamVote experiment23:30 – Why blockchain unlocks faster, more transparent funding than traditional grants26:34 – Remittances, financial access, and the personal case for crypto in emerging markets33:24 – Griff joins: founding Giveth, The DAO hack, and rescuing $200M+ in edge case funds39:21 – The multiplier effect and why matching makes it hard not to donate44:18 – Launching the DAO Security Fund inspired by Octant's model48:45 – AI experiments at Octant, building with AI, and the case for AI in public goods56:29 – Vitalik's L2 tax tweet, Ethereum sustainability, and the need for a security coalition1:00:00 – Rapid fire: execution beats everything and don't count your chickensShow Notes & Mentions

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

CME credits: 0.50 Valid until: 21-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/optimizing-outcomes-in-patients-with-ohcm-the-emerging-role-of-cardiac-myosin-inhibitors/33176/ Hypertrophic cardiomyopathy (HCM) management is being transformed by advances in diagnostics and the emergence of targeted therapies. In this program, leading international experts review challenges in early recognition, the evolving role of beta-blockers and traditional therapies, and the clinical impact of novel cardiac myosin inhibitors. Data from pivotal studies—including the landmark MAPLE-HCM trial—are examined in depth, with a focus on exercise capacity, gradient reduction, biomarkers, and patient outcomes. Faculty also share practical strategies for patient selection, monitoring, and translating trial evidence into daily cardiology practice. =

Jay from AxonDAO breaks down decentralized science in plain English: giving people ownership of health data, enabling ethical AI insights, and funding research via a governed community. We cover live use cases like A+Voice (voice biomarkers for early Alzheimer's/dementia signals) and CureRING+CureOS (a data vault + wearable), plus how AxonDAO supports external researchers and projects (e.g., LymeDAO). Jay also shares a sharp playbook for storytelling, positioning, and growth in frontier tech—who to learn from, what to avoid, and how to keep product, narrative, and feedback loops tight.Key Timestamps[00:00:00] Intro — science x AI x Web3 [00:01:05] Jay's path: SA banking → security → tech → crypto[00:02:40] What AxonDAO is (and isn't): DeSci, data ownership, ethical AI, funding [00:03:35] Projects: A+Voice (voice biomarker analysis)[00:04:35] CureRING + CureOS: wearable + personal health data vault [00:05:45] How AxonDAO supports researchers (network, platform, milestone funding) [00:07:05] Why not start with hospitals/gov data? Design partners and product truth [00:08:20] The hard part of marketing DeSci; proving the model [00:09:35] Explaining DeSci to family: “the commons for science” [00:10:45] Selecting projects: societal value, acceleration potential, founder grit [00:12:05] Storytelling that converts: category, positioning, emotional resonance [00:13:20] Shout-outs: Myosin's Simon Yi; Celestia's Ekram Ahmed; BioProtocol [00:14:40] Three growth tips: talk to users; avoid shiny pivots; roadmap with feedback [00:16:50] Host's advice: ask better questions; product > marketing > sales [00:18:10] Vision (2–3 yrs): self-sovereign health data; infra for global researchers [00:20:05] Challenges ahead: crowded wearables; agentic AI UX; controlled growth [00:21:05] The Ask: Series A opening; looking for ML/AI talent; links & contactConnecthttps://www.axondao.io/https://x.com/Axondaohttps://www.linkedin.com/in/jarrod-frankel/https://x.com/jay_franks91DisclaimerNothing mentioned in this podcast is investment advice and please do your own research. Finally, it would mean a lot if you can leave a review of this podcast on Apple Podcasts or Spotify and share this podcast with a friend.Be a guest on the podcast or contact us - https://www.web3pod.xyz/

Try Katy's Virtual Studio Free for 7 Days!This Episode's Show NotesJoin Our Newsletter: Movement Colored GlassesIf you have heard about eccentric exercise but are unsure of the benefits, what it is or how to do it, this episode is your primer! Eccentric muscle contractions generate more force with less energy than other types of muscle contraction and are therefore one of the best ways to get stronger. The mechanism of eccentric contraction within the muscle is a little complicated but Katy offers a simple analogy involving two hair combs! Katy and Jeannette offer some examples of how you can incorporate eccentrics into your movement plan with the empowering message that you can get a lot stronger doing only half an exercise. Can't do a pull-up? Not a problem, train the eccentric half of the movement—lowering down from the pull-up bar—and you will reap the strength rewards. Also in this episode, Katy speaks with Pack Matthews of Ikaria Design and creator of the Soul Seat®, the original and adjustable cross-legged chair. Katy is using one for her podcast set up and she and Pack talk about the origin of the chair, how the design has changed over time and Katy's experience with it.  CHAPTERS(0:07:08) - Muscle Contraction: Three types (0:15:56) - Sarcomere: Actin, Myosin, and Titin (0:26:57) - Get Stronger Doing Half of an Exercise (0:41:00) - Listener Question: 'use it or lose it' brought to you by Earth Runners  (0:47:40) - Interview with Pack Matthews of Ikaria Design BOOKS, ARTICLES AND RESEARCH MENTIONEDWant to Get Stronger and Avoid Injury, Try This, New York Times article on eccentrics Eccentrics: Get Stronger Doing Half Of An Exercise, Katy Bowman The Chair by Galen CranzMADE POSSIBLE BY OUR SPONSORS:Ikaria Design, creators of the Soul Seat®, a height adjustable chair that allows you to sit in diverse shapes including cross-legged, take 10% of new inventory with code DNA10Venn Design, beautiful floor cushions and ball seats that keep you moving at home or at the officeSmart Playrooms, design and products to keep you and your kids engaged and active at home, take 10% off monkey bars, rock wall panels and holds with code DNA10Earth Runners, minimalist sandals that mimic being truly barefoot through their grounding technology, take 10% off with code DNA10Peluva, Five-toe minimalist sports shoes ideal for walking and higher impact activities, take 15% off with code NUTRITIOUSMOVEMENTSweet Skins, organic hemp and cotton clothing that is stylish, flexible and designed to move with you, take 15% off with code DNA15

For EP31 of Chain Reactions, we sat down with Bettina Sosa — one of the newest guild leads at Myosin and our DevRel whisperer — to unpack why every founder building in crypto needs to treat Developer Relations as a core part of their go-to-market motion.We trace Bettina's path from researching self-sovereign identity at Imperial College (shoutout to her Venezuelan roots and her early hopes to fix broken ID systems) to helping major DAOs like Aragon and Bankless with their onboarding UX. Along the way, she shares what it was like moving from research to shipping product, how she started writing dev-focused content to demystify EVM and MEV, and why so much DevRel in Web3 misses the mark.We go deep on what great DevRel actually looks like — beyond just hackathons and bounties — and explore everything from niche TG groups and cold outreach to AI learning tools, dev onboarding trends, and the regions everyone's sleeping on (spoiler: it's not just Asia anymore).If you're serious about growing your protocol, building developer ecosystems, or just want to understand why “just having docs” won't cut it — this one's for you.Please enjoy, and as always, don't forget to subscribe, give us a five-star review, and mint the episode at pods.media/myosinxyz!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

For EP22 of Chain Reactions, we talked to Rom (@romully), Design Lead at Myosin.xyz, community building extraordinaire, and one of our top designers and brand builders within the network.Rom has an incredible background as a designer, and we had a really fun conversation all around the importance of brand building in the marketing stack in web3, how early stage founders can get started without big budgets, design trends we're seeing, and so much more.Please enjoy, and as always, be sure to subscribe, give us a five star review, and mint our episode at https://pods.media/myosinxyz!

Watch our panel of experts and get up to speed on hypertrophic cardiomyopathy (HCM) through a series of quickfire questions and teaching points. Credit available for this activity expires: 01/31/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-paradigms-hypertrophic-cardiomyopathy-care-gameshow-2025a10002f4?ecd=bdc_podcast_libsyn_mscpedu

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

For EP18 of Chain Reactions, we talked to Alex Poon, Co-Founder of Scout Game and Charmverse, a friend of Myosin, and now repeat guest on the Myosin.xyz podcast.Scout Game is a fantasy sports game targeting developers, but open for anyone to play. With massive initial traction, we talked to Alex all about Scout Games' origins, how the game itself works, and Scout Games broader ambitions for expanding to more blockchains and ecosystems, and eventually the global open-source dev community at large. We're massively bullish on Scout Game, and think is an excellent listen for anyone who cares about developer marketing, gamification, and how to build products that are both fun and really solve a clear need. Please enjoy, and as always, be sure to subscribe, give us a five star review, and mint our episode at https://pods.media/myosinxyz!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

For EP16 of Chain Reactions, hot off the release of our Crypto in Argentina report, we talked to Mike Tango Bravo, Founder of Open Vino DAO and a Crecimiento community member, and Tay Todd, our Innovation Genius who helped write Myosin's Crypto in Argentina report. During our chat we talked all about the unique nature of Argentina's economic history and relationship with crypto, and just how and why it's so keen to adopt crypto with even government support and encouragement, as well as the unique and incredible nature of how Open Vino DAO is helping tokenize and democratize access to one of the oldest industries in the world: winemaking.This is a great listen for anyone trying to understand why crypto matters, and how it's fast gaining adoption in countries such as Argentina. Links below! https://bit.ly/myosin-argentina-rr https://x.com/crecimientoar https://openvino.org/

For EP14 of Chain Reactions, we chatted with James Fry, Head of Marketing for Risk Labs, the foundation and core team behind UMA & Across Protocols.We jammed out with James on why we need more protocols like UMA Protocol, which helps decentralized truth telling and powers popular prediction markets like Polymarket, and Across Protocol, which helps streamline and drastically improve cross-chain crypto transactions with what we call decentralized 'intents.' This was a big brain chat, and a great listen for anyone interested in the future of blockchain! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP13 of Chain Reactions, we chatted with Kim Currier, Head of Partnership & Growth for Decentraland, one of the leading platforms for communities to gather and interact in virtual economies. We had a delightful time chatting with Kim about the latest updates to Decentraland and Decentraland 2.0, their gamification efforts, and waxing poetic about what the metaverse really is. Kim shared a lot of really interesting insights into the challenges and unique opportunities that marketing a world like Decentraland can bring for brands and companies of all kinds, and she also included some alpha that you definitely don't want to miss. Take a listen! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP12 of Chain Reactions, we chatted with Nicole Rochette, Innovation Guild Lead at Myosin.xyz, and an onchain marketing OG, having spent a long career in traditional marketing, and being a critical part of the early days at Dapper Labs, one of the leading onchain companies in the last cycle and beyond. We had a great session yapping with Nicole all around her journey, how she found her way into crypto, lessons learned, and just what has changed in the past four years as the market has continued to evolve. We even had a special guest appearance from a fluffy friend...bark. This ones a great listen for anyone interested in entering crypto! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP11 of Chain Reactions, we had a great convo with Will Leatherman (@wleatherman9), Myosin Content Guild Lead, and Founder of Catalyst, a content-led growth platform, chatting all about Founder-Led Marketing. We talked all about the differences between LinkedIn and Twitter content creation, the importance of staying consistent, and some actionable tips and tricks on how to gain traction with founder-led content. If you're interested in growing your audiences and company, this is an excellent listen! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP10 of Chain Reactions, we had Crypto Bae (@encryptedbae), a Solana KOl and chain-agnostic marketing extraordinaire, hop on the livestream to jam about onchain marketing. We talked about Solana Villa in Dubai, her fascinating experiment where she offered free chats for her Twitter followers and what she learned, and much more, all while trying not to get distracted by the army of cats running around in the background. What a fun chat! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP9 of Chain Reactions, we had Adelia join us again on the livestream to talk about and recap the insanity of Token2049 and Breakpoint in Singapore. Together, we talked about the crazy parties, our key takeaways and favorite events, some major alpha, and also played a fun game of conference bingo, all facetiously sponsored by Bintang Beer. Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST!

Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.  Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496 

For EP8 of Chain Reactions, we were joined by 0xSoju, one of the leading cats at Jupiter, the leading DEX aggregator in Solana, to talk all about airdrops and token launches. We also had Xindaquil, a Myosin member and leading marketer in crypto, join us as a co-host. Together, we dove deep into the secret sauce between Jupiter's token launch, their marketing team (or lack thereof), and waxed poetic on what onchain teams should consider when launching a token. Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST!

Dr. Gordon Smith talks with Drs. Shahar Shelly and Teerin Liewluck about the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. Read the related article in Neurology.  Disclosures can be found at Neurology.org.

For EP7 of Chain Reactions, we had James Chi, Co-Founder of Camp Network, a fast growing Layer 2 blockchain, tell us all about how Camp is building the future of identity through both offchain and onchain social profiles. We also had a blast diving into Camp's amazing social strategy, and went nuts (in a good way) discussing the power of the Camp community. Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST!

Hi, and welcome to Chain Reactions, a weekly livestream from Myosin.xyz, the leading global marketing network, and hosted by yours truly, Blake, and my cohost Polina. Tune in each week as we jam on the latest happenings in the wild and wonderful world of web3. This week we dive into topics such as Berachain, Fuse and is Iggy Azalea actually this involved in memcoins?

This month, how animals hibernate and evidence that muscle myosin makes its own heat in the cold, brain scans to reveal how ketamine relieves resistant depression, the way the brain changes when animals build a bond, the evolution of flu outbreaks, and how aphantasia affects autobiographical memory. Get the references and the transcripts for this programme from the Naked Scientists website

Drop 1: GoDaddy + ENShttps://blog.ens.domains/post/godaddy-partners-with-ensDrop 2: Cardano migrates to Intersecthttps://www.intersectmbo.org/news/open-horizons-cardano-migrates-to-intersectDrop 3: Farcaster Frames https://thedefiant.io/socialfi-app-farcaster-s-activity-spikes-after-launching-frames-feature .. More: FCA review paper on MEV and Oracleshttps://www.fca.org.uk/publications/research-notes/research-note-review-maximal-extractable-value-and-blockchain-oraclesDigital Pound Foundation published their response to the BoE Discussion Paper on the Regulatory regime for systemic payment systems using stablecoins and related service providers.https://www.linkedin.com/posts/jannahpatchay_dpf-response-boe-discussion-paper-on-systemic-ugcPost-7160288781625909248-NRVSSouth Korean Regulator to Discuss Spot Bitcoin ETF With U.S. SEChttps://www.coindesk.com/policy/2024/02/05/south-korean-regulator-to-discuss-spot-bitcoin-etf-with-us-sec-report/Former NBA star Dwight Howard dunks on fans with troublesome NFT launchhttps://sportingcrypto.substack.com/p/former-nba-star-dwight-howards-disastrousCardano Foundation publishes its 2023 Activity Reporthttps://cardanofoundation.org/pdf/cardano-foundation-activity-report-2023.pdfm0 published its whitepaper - Reconstructing the Monetary Stackhttps://research.m0.org/research/reconstructing-the-monetary-stackSofto launches BeyondBold, a new web3 agencyhttps://sof.to/pt-BR/for-companies/beyondbold-labsBitso's new report: Crypto Landscape in Latin Americahttps://bitso.com/mx/crypto-landscape-2023Polygon Releases 'Type 1 Prover', promises further ZK interoperabilityhttps://www.coindesk.com/tech/2024/02/08/polygon-releases-type-1-prover-claiming-milestone-set-by-ethereums-vitalik-buterin/Digitra announces "crypto dividends", a passive income product for assets under custodyhttps://br.cointelegraph.com/news/crypto-news-digita-announces-new-services-sustainable-bitcoin-on-hathor-and-other-newsFuture of Sports Fandom, new report by Sporting Crypto, Myosin and Spartan Labshttps://docsend.com/view/6gy39qmad89qzxb7Black Mirror and Pixelynx launch smile to earn experience https://decrypt.co/215410/black-mirror-goes-web3-with-pixelynx-smile-to-earn-experienceMobiup releases web3 upskill coursehttps://webitcoin.com.br/mobiup-lanca-curso-capacitar-desenvolvedores-web2/ . Redes sociais / comunicação.. Instagram.com/blockdropspodcast.. Twitter.com/blockdropspod.. Blockdrops.lens .. https://warpcast.com/mauriciomagaldi.. youtube.com/@BlockDropsPodcast.. Meu conteúdo em inglês twitter.com/0xmauricio.. Newsletter do linkedin https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272.. blockdropspodcast@gmail.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/blockdropspodcast/message

Drop 1: GoDaddy + ENS ⁠https://blog.ens.domains/post/godaddy-partners-with-ens⁠ Drop 2: Cardano migrates to Intersect ⁠https://www.intersectmbo.org/news/open-horizons-cardano-migrates-to-intersect⁠ Drop 3: Farcaster Frames ⁠https://thedefiant.io/socialfi-app-farcaster-s-activity-spikes-after-launching-frames-feature⁠ .. More: FCA review paper on MEV and Oracles ⁠https://www.fca.org.uk/publications/research-notes/research-note-review-maximal-extractable-value-and-blockchain-oracles⁠ Digital Pound Foundation published their response to the BoE Discussion Paper on the Regulatory regime for systemic payment systems using stablecoins and related service providers. ⁠https://www.linkedin.com/posts/jannahpatchay_dpf-response-boe-discussion-paper-on-systemic-ugcPost-7160288781625909248-NRVS⁠ South Korean Regulator to Discuss Spot Bitcoin ETF With U.S. SEC ⁠https://www.coindesk.com/policy/2024/02/05/south-korean-regulator-to-discuss-spot-bitcoin-etf-with-us-sec-report/⁠ Former NBA star Dwight Howard dunks on fans with troublesome NFT launch ⁠https://sportingcrypto.substack.com/p/former-nba-star-dwight-howards-disastrous⁠ Cardano Foundation publishes its 2023 Activity Report ⁠https://cardanofoundation.org/pdf/cardano-foundation-activity-report-2023.pdf⁠ m0 published its whitepaper - Reconstructing the Monetary Stack ⁠https://research.m0.org/research/reconstructing-the-monetary-stack⁠ Softo launches BeyondBold, a new web3 agency ⁠https://sof.to/pt-BR/for-companies/beyondbold-labs⁠ Bitso's new report: Crypto Landscape in Latin America ⁠https://bitso.com/mx/crypto-landscape-2023⁠ Polygon Releases 'Type 1 Prover', promises further ZK interoperability ⁠https://www.coindesk.com/tech/2024/02/08/polygon-releases-type-1-prover-claiming-milestone-set-by-ethereums-vitalik-buterin/⁠ Digitra announces "crypto dividends", a passive income product for assets under custody ⁠https://br.cointelegraph.com/news/crypto-news-digita-announces-new-services-sustainable-bitcoin-on-hathor-and-other-news⁠ Future of Sports Fandom, new report by Sporting Crypto, Myosin and Spartan Labs ⁠https://docsend.com/view/6gy39qmad89qzxb7⁠ Black Mirror and Pixelynx launch smile to earn experience ⁠https://decrypt.co/215410/black-mirror-goes-web3-with-pixelynx-smile-to-earn-experience⁠ Mobiup releases web3 upskill course ⁠https://webitcoin.com.br/mobiup-lanca-curso-capacitar-desenvolvedores-web2/⁠ . Redes sociais / comunicação .. ⁠Instagram.com/blockdropspodcast⁠ .. ⁠Twitter.com/blockdropspod⁠ .. Blockdrops.lens .. ⁠https://warpcast.com/mauriciomagaldi⁠ .. ⁠youtube.com/@BlockDropsPodcast⁠ .. Meu conteúdo em inglês ⁠twitter.com/0xmauricio⁠ .. Newsletter do linkedin ⁠https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272⁠ .. ⁠blockdropspodcast@gmail.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/blockdropspodcast/message

Genjo Marinello Osho gave this Teisho during the Jan. 14, 2024 Zazenkai at Chobo-Ji. This talk examines how to meet criticisms and mistakes or well or poorly.

Tune in for the first episode of our second season of the official Myosin.xyz podcast, Netcetera, fka W3G! We spoke with Alex Webbs, Innovation Co-Lead at Myosin.xyz, and a member of the Digital Strategy team at PUMA, a leading brand in the world of culture and sports. Alex is a deeply experienced marketer in the world of web3, tech, and culture, having consulted for clients such as Shiseido, Water & Music, NFT.NYC, Ready Player Me, and many more. If you're interested in learning about how brands think about web3 and innovation, this is a great listen. So without further ado, let's get into it. Here is Episode #1 with Alex Webbs!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

With all the buzz about Web3 and technological advancements, marketing and agency life is poised to change rapidly. One agency model that works well in the Web3 world is a DAO, or Decentralized Autonomous Organization. Today, Matthew Mozzocchi is here to talk about Myosin, a DAO agency, and how this model allows them to have a leg up the Web3 world. This week, episode 190 of The Digital Agency Growth Podcast is about Web 3, the DAO team model, and profitable agency partnerships!Are you leaving money on the table with your proposals? Introducing Smart Pricing Table, the ultimate agency proposal software with built-in upsell features. Maximize your revenue potential today. Download our Sponsor's free guide, the Profitable Proposal Blueprint, today. In this episode of The Digital Agency Growth Podcast, Matthew Mozzocchi shares the importance of partnering with agencies in a mutually beneficial way and actionable steps you can take right now to understand the underlying tech of Web3.Matthew Mozzocchi is the Head of Revenue Operations at Myosin, a product studio and agency leveraging the collective wisdom of our member base to inform the tools, processes and playbooks that drive user acquisition into web3. Matthew also helps agencies and Fortune 100 businesses solve their complex staffing needs with flexible talent solutions. In this episode, Dan and Matthew discuss the following:What a DAO (Decentralized Autonomous Organization) is and how it works.The value of partnership models that actually benefit both parties.How Web3 and Web2 differ and how we can expect to see Web3 grow in the next few years.The importance of getting in front of different audiences when partnering.Thank you for listening! If you enjoyed this episode, please take a moment to follow, rate and review the podcast and tell me your key takeaways!Learn more about The Digitial Agency Growth Podcast at https://www.salesschema.com/podcast/ and Smart Pricing Table at https://www.smartpricingtable.com/dagCONNECT WITH MATTHEW MOZZOCCHI:LinkedInMozz.coMyosin.xyzCONNECT WITH DAN ENGLANDER:LinkedInSales Schema